 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.14.1
- Dipeptidyl-peptidase I.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Release of an N-terminal dipeptide, Xaa-Xbb-|-Xcc, except when Xaa is Arg or Lys, or Xbb or Xcc is Pro.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
endoplasmic reticulum
|
3 terms
|
 |
|
Biological process
|
aging
|
3 terms
|
 |
|
Biochemical function
|
hydrolase activity
|
7 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
FEBS Lett
506:201-206
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Tetrameric dipeptidyl peptidase I directs substrate specificity by use of the residual pro-part domain.
|
|
J.G.Olsen,
A.Kadziola,
C.Lauritzen,
J.Pedersen,
S.Larsen,
S.W.Dahl.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of mature dipeptidyl peptidase I reveals insight into the
unique tetrameric structure, substrate binding and activation of this atypical
papain family peptidase. Each subunit is composed of three peptides. The heavy
and light chains form the catalytic domain, which adopts the papain fold. The
residual pro-part forms a beta-barrel with the carboxylate group of Asp1
pointing towards the substrate amino-terminus. The tetrameric structure appears
to stabilize the association of the two domains and encloses a 12700 A3
spherical cavity. The tetramer contains six chloride ions, one buried in each S2
pocket and two at subunit interfaces.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. The fold and domain structure of DPPI. A: A ribbon
trace of of the subunit which consists of three polypeptide
chains in the activated enzyme: the 118 residue long residual
pro-part to the left (shown in turquoise) and the heavy and
light chains (shown in magenta and orange, respectively)
which constitute the papain fold domain. The pale yellow spheres
represent chloride ions. Active site residues Cys233 and His380
as well as N-acetylglucosamine residues and their associated
asparagines are shown in ball-and-stick representation. B: The
eight-stranded meander β-barrel residual pro-part domain is
rainbow-colored such that residue 1 is blue and residue 118 is
red. Chlorides are represented by pale yellow spheres and Asp1
and the active site nucleophile are shown in ball-and-stick
representation. The papain fold core domain is shown in the
background. C: The tetrameric structure of DPPI. Residual
pro-part domains are shown in gray and the papain fold domain in
red, yellow, blue, and green, representing the different
subunits. The tetramer assembles around the crystallographic
2-fold axes with one subunit in the asymmetric unit. Figures
were prepared in Molscript [28].
|
 |
Figure 2.
Fig. 2. The DPPI active site. A: The catalytic residues
Cys233 and His380 and the substrate binding Asp1 residue are
shown in ball-and-stick. Also shown is the chloride ion
positioned at the N-terminus of the distorted helix 3. B:
Electron density map contoured at 1.2σ superimposed on the
model around the active site/substrate binding cleft. Figures
prepared in Molscript [28] and TURBO-FRODO [19].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the Federation of European Biochemical Societies:
FEBS Lett
(2001,
506,
201-206)
copyright 2001.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.S.Mahajan,
E.Deu,
E.M.Lauterwasser,
M.J.Leyva,
J.A.Ellman,
M.Bogyo,
and
A.R.Renslo
(2011).
A fragmenting hybrid approach for targeted delivery of multiple therapeutic agents to the malaria parasite.
|
| |
ChemMedChem, 6,
415-419.
|
 |
|
|
|
|
 |
E.Deu,
M.J.Leyva,
V.E.Albrow,
M.J.Rice,
J.A.Ellman,
and
M.Bogyo
(2010).
Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes.
|
| |
Chem Biol, 17,
808-819.
|
 |
|
|
|
|
 |
M.Kurban,
M.Wajid,
Y.Shimomura,
R.Bahhady,
A.G.Kibbi,
and
A.M.Christiano
(2009).
Evidence for a founder mutation in the cathepsin C gene in three families with Papillon-Lefèvre syndrome.
|
| |
Dermatology, 219,
289-294.
|
 |
|
|
|
|
 |
K.Hirasaka,
K.Tokuoka,
R.Nakao,
C.Yamada,
M.Oarada,
T.Imagawa,
K.Ishidoh,
Y.Okumura,
K.Kishi,
and
T.Nikawa
(2008).
Cathepsin C propeptide interacts with intestinal alkaline phosphatase and heat shock cognate protein 70 in human Caco-2 cells.
|
| |
J Physiol Sci, 58,
105-111.
|
 |
|
|
|
|
 |
A.Rossi,
Q.Deveraux,
B.Turk,
and
A.Sali
(2004).
Comprehensive search for cysteine cathepsins in the human genome.
|
| |
Biol Chem, 385,
363-372.
|
 |
|
|
|
|
 |
M.Klemba,
I.Gluzman,
and
D.E.Goldberg
(2004).
A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation.
|
| |
J Biol Chem, 279,
43000-43007.
|
 |
|
|
|
|
 |
D.K.Nägler,
and
R.Ménard
(2003).
Family C1 cysteine proteases: biological diversity or redundancy?
|
| |
Biol Chem, 384,
837-843.
|
 |
|
|
|
|
 |
D.Turk,
and
G.Guncar
(2003).
Lysosomal cysteine proteases (cathepsins): promising drug targets.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
203-213.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|